期刊
CELL
卷 170, 期 3, 页码 414-427出版社
CELL PRESS
DOI: 10.1016/j.cell.2017.07.009
关键词
-
资金
- National Institute of Health [RO1MH112205, UO1MH104974, U19MH82441, PO1DA035764]
- Michael Hooker Distinguished Professorship
G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome. Recent structural and molecular studies have both transformed and expanded classical concepts of receptor pharmacology and have begun to illuminate the distinct mechanisms by which structurally, chemically, and functionally diverse ligands modulate GPCR function. These molecular insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compounds, especially for understudied and orphan GPCRs. These advances promise to streamline the development of GPCR-targeted medications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据